206 related articles for article (PubMed ID: 12112317)
1. Transgene stability and features of rasH2 mice as an animal model for short-term carcinogenicity testing.
Suemizu H; Muguruma K; Maruyama C; Tomisawa M; Kimura M; Hioki K; Shimozawa N; Ohnishi Y; Tamaoki N; Nomura T
Mol Carcinog; 2002 May; 34(1):1-9. PubMed ID: 12112317
[TBL] [Abstract][Full Text] [Related]
2. Loss of palindromic symmetry in Tg.AC mice with a nonresponder phenotype.
Honchel R; Rosenzweig BA; Thompson KL; Blanchard KT; Furst SM; Stoll RE; Sistare FD
Mol Carcinog; 2001 Feb; 30(2):99-110. PubMed ID: 11241757
[TBL] [Abstract][Full Text] [Related]
3. Integration of a c-myc transgene results in disruption of the mouse Gtf2ird1 gene, the homologue of the human GTF2IRD1 gene hemizygously deleted in Williams-Beuren syndrome.
Durkin ME; Keck-Waggoner CL; Popescu NC; Thorgeirsson SS
Genomics; 2001 Apr; 73(1):20-7. PubMed ID: 11352562
[TBL] [Abstract][Full Text] [Related]
4. Radial transformation-associated recombination cloning from the mouse genome: isolation of Tg.AC transgene with flanking DNAs.
Humble MC; Kouprina N; Noskov VN; Graves J; Garner E; Tennant RW; Resnick MA; Larionov V; Cannon RE
Genomics; 2000 Dec; 70(3):292-9. PubMed ID: 11161779
[TBL] [Abstract][Full Text] [Related]
5. A postimplantation lethal mutation induced by transgene insertion on mouse chromosome 8.
Pravtcheva DD; Wise TL
Genomics; 1995 Dec; 30(3):529-44. PubMed ID: 8825640
[TBL] [Abstract][Full Text] [Related]
6. [Analysis, identification and correction of some errors of model refseqs appeared in NCBI Human Gene Database by in silico cloning and experimental verification of novel human genes].
Zhang DL; Ji L; Li YD
Yi Chuan Xue Bao; 2004 May; 31(5):431-43. PubMed ID: 15478601
[TBL] [Abstract][Full Text] [Related]
7. The rasH2 transgenic mouse: nature of the model and mechanistic studies on tumorigenesis.
Tamaoki N
Toxicol Pathol; 2001; 29 Suppl():81-9. PubMed ID: 11695564
[TBL] [Abstract][Full Text] [Related]
8. The Tg rasH2 mouse in cancer hazard identification.
Morton D; Alden CL; Roth AJ; Usui T
Toxicol Pathol; 2002; 30(1):139-46. PubMed ID: 11890467
[TBL] [Abstract][Full Text] [Related]
9. Biological, cellular, and molecular characteristics of an inducible transgenic skin tumor model: a review.
Humble MC; Trempus CS; Spalding JW; Cannon RE; Tennant RW
Oncogene; 2005 Dec; 24(56):8217-28. PubMed ID: 16355251
[TBL] [Abstract][Full Text] [Related]
10. Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice.
Yamamoto S; Mitsumori K; Kodama Y; Matsunuma N; Manabe S; Okamiya H; Suzuki H; Fukuda T; Sakamaki Y; Sunaga M; Nomura G; Hioki K; Wakana S; Nomura T; Hayashi Y
Carcinogenesis; 1996 Nov; 17(11):2455-61. PubMed ID: 8968063
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse.
Nesfield SR; Clarke CJ; Hoivik DJ; Miller RT; Allen JS; Selinger K; Santostefano MJ
Int J Toxicol; 2005; 24(5):301-11. PubMed ID: 16257850
[TBL] [Abstract][Full Text] [Related]
12. Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing.
Yamamoto S; Urano K; Koizumi H; Wakana S; Hioki K; Mitsumori K; Kurokawa Y; Hayashi Y; Nomura T
Environ Health Perspect; 1998 Feb; 106 Suppl 1(Suppl 1):57-69. PubMed ID: 9539005
[TBL] [Abstract][Full Text] [Related]
13. Carcinogen dose-dependent variation in the transgene mutation spectrum in urethane-induced lung tumors in transgenic mice carrying the human prototype c-Ha-ras gene.
Mori I; Yasuhara K; Hayashi SM; Nonoyama T; Nomura T; Mitsumori K
Cancer Lett; 2000 May; 153(1-2):199-209. PubMed ID: 10779650
[TBL] [Abstract][Full Text] [Related]
14. Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies.
Mitsumori K; Koizumi H; Nomura T; Yamamoto S
Toxicol Pathol; 1998; 26(4):520-31. PubMed ID: 9715511
[TBL] [Abstract][Full Text] [Related]
15. Characterization of transgene integration pattern in F4 hGH-transgenic common carp (Cyprinus carpio L.).
Wu B; Sun YH; Wang YW; Wang YP; Zhu ZY
Cell Res; 2005 Jun; 15(6):447-54. PubMed ID: 15987603
[TBL] [Abstract][Full Text] [Related]
16. Establishing a laboratory animal model from a transgenic animal: RasH2 mice as a model for carcinogenicity studies in regulatory science.
Urano K; Tamaoki N; Nomura T
Vet Pathol; 2012 Jan; 49(1):16-23. PubMed ID: 22146850
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide SNP analysis of Tg.AC transgenic mice reveals an oncogenic collaboration between v-Ha-ras and Ink4a, which is absent in p53 deficiency.
Leder A; McMenamin J; Zhou F; Moran JL; Beier DR; Leder P
Oncogene; 2008 Apr; 27(17):2456-65. PubMed ID: 17952114
[TBL] [Abstract][Full Text] [Related]
18. Use of rasH2 transgenic mice for carcinogenesis testing of medical implants.
Palazzi X; Kergozien-Framery S
Exp Toxicol Pathol; 2009 Sep; 61(5):433-41. PubMed ID: 19062264
[TBL] [Abstract][Full Text] [Related]
19. Rapid carcinogenicity testing system with transgenic mice harboring human prototype c-HRAS gene.
Yamamoto S; Hayashi Y; Mitsumori K; Nomura T
Lab Anim Sci; 1997 Apr; 47(2):121-6. PubMed ID: 9150488
[TBL] [Abstract][Full Text] [Related]
20. Di(2-ethylhexyl)phthalate induces hepatocellular adenoma in transgenic mice carrying a human prototype c-Ha-ras gene in a 26-week carcinogenicity study.
Toyosawa K; Okimoto K; Kobayashi I; Kijima K; Kikawa E; Kohchi M; Koujitani T; Tanaka K; Matsuoka N
Toxicol Pathol; 2001; 29(4):458-66. PubMed ID: 11560251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
